15:22:26 EDT Fri 26 Apr 2024
Enter Symbol
or Name
USA
CA



T:MSCL - SATELLOS BIOSCIENCE INC. - https://satellos.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MSCL - T  9.50.48·0.4953.00.48+0.049.164.629330.45  0.495  0.450.80  0.2914:55:45Apr 0815 min RT 2¢
TSX - T9.50.48·0.4953.00.48+0.049.129.21470.45  0.495  0.450.80  0.2914:55:4515 min
NEO ATS - U 0.48+0.049.16.0350.48  0.48  0.4812:42:3615 min
Omega - O 0.48+0.049.14.0220.48  0.48  0.4812:42:3615 min
Pure - P 0.495+0.05512.51.0020.48  0.495  0.4813:51:5215 min
Chi-X - X 0.48+0.049.11.0010.48  0.48  0.4810:19:2115 min
CX2 - H 0.48+0.049.123.011120.48  0.495  0.4814:55:4515 min
CXD - D 0.440.32    Apr 2515 min
TriAct - M 0.440.12    15 min

Recent Trades - Last 10 of 33
Time ETExPriceChangeVolumeBuyerSellerMarkers
14:55:45T0.480.0410,5009 BMO Nesbitt9 BMO NesbittK
14:55:45H0.480.045007 TD Sec9 BMO NesbittK
14:55:45H0.480.043,5002 RBC9 BMO NesbittK
14:55:45H0.480.043,5001 Anonymous9 BMO NesbittK
14:55:45H0.480.041,5002 RBC9 BMO NesbittK
14:55:45H0.480.045002 RBC9 BMO NesbittK
14:16:37M0.4950.0551201 Anonymous2 RBC
14:04:32H0.4950.0551,5009 BMO Nesbitt2 RBCK
14:04:32H0.4950.0553,5009 BMO Nesbitt1 AnonymousK
13:58:12D0.4950.0552007 TD Sec7 TD SecE

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-03-27 16:42C:MSCL0.48SEDAR MD & ASEDAR MD & A
2024-03-27 15:50C:MSCL0.46SEDAR MD & ASEDAR MD & A
2024-03-27 15:44C:MSCL0.46SEDAR Annual Information FormSEDAR Annual Information Form
2024-03-27 15:44C:MSCL0.46SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-03-27 11:14C:MSCL0.48News ReleaseSatellos Bioscience's Dec. 31 cash at $39.6-million
2024-02-14 11:10C:MSCL0.55News ReleaseSatellos Bioscience to begin trading on TSX Feb. 15
2024-02-13 19:56C:MSCL0.55Shares Delisted from TSX-VSatellos Bioscience to be delisted from TSX-V
2024-02-13 15:01C:MSCL0.55New ListingSatellos Bioscience to trade on TSX Feb. 15
2024-02-13 11:19C:MSCL0.53News ReleaseSatellos Bioscience releases SAT-3247 preliminary data
2024-01-26 11:38C:MSCLSEDAR Final Short Form ProspectusSEDAR Final Short Form Prospectus
2024-01-23 10:08C:MSCL0.55News ReleaseSatellos names Dubow chief medical adviser
2024-01-16 11:45C:MSCL0.45News ReleaseSatellos Bioscience receives cond. OK for TSX listing
2023-11-22 14:30C:MSCL0.50SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-22 14:28C:MSCL0.50SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-22 10:41C:MSCL0.475News ReleaseSatellos Bioscience's Sept. 30 cash at $44.3-million
2023-11-14 13:38C:MSCL0.35News ReleaseSatellos sets AAK1 as drug target to treat Duchenne
2023-09-07 17:15C:MSCL0.495News ReleaseSatellos hires ICP for market making services
2023-09-05 14:28C:MSCL0.415News ReleaseSatellos Bioscience appoints Williams as CFO
2023-08-29 12:50C:MSCL0.45News ReleaseSatellos Bioscience spends $873,012 on R&D in Q2
2023-08-28 07:02C:MSCL0.45SEDAR Interim Financial StatementsSEDAR Interim Financial Statements